{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:24:52Z","timestamp":1783747492778,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Design of experiments has emerged as an influential and proactive approach that demonstrated favored applicability in optimizing chromatographic procedures. Quality-by-design guarantees the long-standing efficiency of the developed HPLC method reducing the need for costly and resource-intensive univariate approach. A low environmental footprint, sensitive, fast, and simple HPLC method was developed for concurrent estimation of cefixime (CFX) and ornidazole (ORN) in their raw materials, laboratory-prepared tablets, and pharmaceutical formulations using 2\n                    <jats:sup>3<\/jats:sup>\n                    full factorial design. The separation was performed on a cyano column through UV detection at 300\u00a0nm in less than 4\u00a0min. The elution was achieved using a mobile phase (pH\u2009=\u20096.0) composed of methanol and 0.3% triethylamine in ratio of (85%: 15%, v\/v), respectively with a flow rate of 1 mL\/min. The method\u2019s validity was established with ICH\n                    <jats:inline-formula>\n                      <jats:tex-math>$$\\:{\\text{Q}}_{2}{\\text{R}}_{1}$$<\/jats:tex-math>\n                    <\/jats:inline-formula>\n                    regulations. Excellent linear correlation (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.9999) was established within concentration ranges lies between 1 and 50\u00a0\u00b5g\/mL and 0.5\u201350\u00a0\u00b5g\/mL with high percent found of 100.04\u2009\u00b1\u20090.82 and 99.99\u2009\u00b1\u20091.01 for CFX and ORN, respectively. The approach exhibited high precision (% RDS\u2009&lt;\u20092) and sensitivity with detection limits of 0.07 and 0.09\u00a0\u00b5g\/mL and quantification limits of 0.21 and 0.28\u00a0\u00b5g\/mL for CFX and ORN, respectively. Several metrics evidenced the method\u2019s greenness and sustainability profile.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-51859-3","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:25:25Z","timestamp":1779805525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emerging quality-by-design optimized HPLC method for the concurrent determination of cefixime and ornidazole: a multi-criteria green and blue environmental footprinting"],"prefix":"10.1038","volume":"16","author":[{"given":"Yasmeen E.","family":"Mostafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi","family":"Elsebaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed El-Sayed","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"51859_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jssc.201900656","volume":"43","author":"AA Dar","year":"2020","unstructured":"Dar, A. A., Sangwan, P. & Kumar, A. Chromatography: An important tool for drug discovery. J. Sep. Sci. 43, 105\u2013119 (2020).","journal-title":"J. Sep. Sci."},{"key":"51859_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jpba.2018.11.027","volume":"164","author":"J Jacyna","year":"2019","unstructured":"Jacyna, J., Kordalewska, M. & Markuszewski, M. J. Design of experiments in metabolomics-related studies: An overview. J. Pharm. Biomed. Anal. 164, 598\u2013606 (2019).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"51859_CR3","doi-asserted-by":"crossref","unstructured":"Sahoo, P. & Barman, T. K. 5 - ANN modelling of fractal dimension in machining. In Mechatronics and Manufacturing Engineering (ed. Davim, J. P.) 159\u2013226 (Woodhead Publishing, 2012).","DOI":"10.1533\/9780857095893.159"},{"key":"51859_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.70129","volume":"39","author":"SK Ettaboina","year":"2025","unstructured":"Ettaboina, S. K., Nannapaneni, S., Katari, N. K. & Chollety, V. K. Development and validation of an RP-HPLC method for organic impurity profiling in baclofen utilizing robustness through a Quality\u2010by\u2010Design (QbD) approach: A comprehensive forced degradation assessment. Biomed. Chromatogr. 39, e70129 (2025).","journal-title":"Biomed. Chromatogr."},{"key":"51859_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.6001","volume":"38","author":"SK Ettaboina","year":"2024","unstructured":"Ettaboina, S. K. et al. Development, evaluation of critical method variables and stability assessment using a Box\u2013Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone. Biomed. Chromatogr. 38, e6001 (2024).","journal-title":"Biomed. Chromatogr."},{"key":"51859_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acssynbio.0c00385","volume":"10","author":"J Gilman","year":"2021","unstructured":"Gilman, J., Walls, L., Bandiera, L. & Menolascina, F. Statistical design of experiments for synthetic biology. ACS Synth. Biol. 10, 1\u201318 (2021).","journal-title":"ACS Synth. Biol."},{"key":"51859_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trac.2014.07.009","volume":"62","author":"MP Callao","year":"2014","unstructured":"Callao, M. P. Multivariate experimental design in environmental analysis. TRAC Trends Anal. Chem. 62, 86\u201392 (2014).","journal-title":"TRAC Trends Anal. Chem."},{"key":"51859_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tifs.2017.11.013","volume":"71","author":"P Yu","year":"2018","unstructured":"Yu, P., Low, M. Y. & Zhou, W. Design of experiments and regression modelling in food flavour and sensory analysis: A review. Trends Food Sci. Technol. 71, 202\u2013215 (2018).","journal-title":"Trends Food Sci. Technol."},{"key":"51859_CR9","unstructured":"The British Pharmacopoeia. Her Majesty\u2019s Stationery Office, Electronic Version, London, UK, 1. 2011416 (2022)."},{"key":"51859_CR10","volume-title":"Lippincott\u00ae Illustrated Reviews: Pharmacology","author":"K Whalen","year":"2018","unstructured":"Whalen, K. Lippincott\u00ae Illustrated Reviews: Pharmacology Sixth edition. (Wolters kluwer india Pvt Ltd, 2018).","edition":"Sixth edition"},{"key":"51859_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2016.03.042","volume":"505","author":"M Imran","year":"2016","unstructured":"Imran, M. et al. Glycoside-based niosomal nanocarrier for enhanced in-vivo performance of cefixime. Int. J. Pharm. 505, 122\u2013132 (2016).","journal-title":"Int. J. Pharm."},{"key":"51859_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.51847\/LstEumAkic","volume":"11","author":"EG Jabbar","year":"2021","unstructured":"Jabbar, E. G., Al-Tamimi, D. J. J., Al-Mahroos, M. I. A., Al-Tamimi, Z. J. J. & Ibraheem, J. J. Pharmacokinetics and bioequivalence study of two formulations of cefixime suspension. J. Adv. Pharm. Educ. Res. 11, 170\u2013177 (2021).","journal-title":"J. Adv. Pharm. Educ. Res."},{"key":"51859_CR13","volume-title":"Martindale: The Complete Drug Reference","author":"SC Sweetman","year":"2020","unstructured":"Sweetman, S. C. Martindale: The Complete Drug Reference 40th edition. (Pharmacutical Press, 2020).","edition":"40th edition"},{"key":"51859_CR14","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox, C. et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic acids Res. 52, D1265-d1275 (2024).","journal-title":"Nucleic acids Res."},{"key":"51859_CR15","doi-asserted-by":"crossref","unstructured":"Singh, P., Mittal, R., Sharma, G. C., Singh, S. & Singh, A. Ornidazole: Comprehensive Profile. In Profiles of Drug Substances, Excipients and Related Methodology (ed. Brittain, H. G.) 123\u2013184 (Academic Press, 2003).","DOI":"10.1016\/S0099-5428(03)30007-3"},{"key":"51859_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40268-024-00457-7","volume":"24","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Evaluation of ornidazole tablets bioequivalence in Chinese healthy participants under fasted and fed conditions using pharmacokinetic parameters. Drugs R. D. 24, 145\u2013154 (2024).","journal-title":"Drugs R. D."},{"key":"51859_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.18203\/2319-2003.ijbcp20195789","volume":"9","author":"S Murugesan","year":"2019","unstructured":"Murugesan, S., Raj, G. M. & Adhimoolam, M. Cefixime and ornidazole combination induced fixed drug eruption: A case report. Int. J. Basic Clin. Pharmacol. 9, 211\u2013214 (2019).","journal-title":"Int. J. Basic Clin. Pharmacol."},{"key":"51859_CR18","first-page":"46","volume":"3","author":"KS Khandagle","year":"2011","unstructured":"Khandagle, K. S., Gandhi, S. V., Deshpande, P. B. & Gaikwad, N. V. A simple and sensitive RPHPLC method for simultaneous estimation of cefixime and ofloxacin in combined tablet dosage form. Int. J. Pharm. Pharm. Sci. 3, 46\u201348 (2011).","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"51859_CR19","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1081\/JLC-100105143","volume":"24","author":"R Gonz\u00e1lez-Hern\u00e1ndez","year":"2001","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez, R., Nuevas-Paz, L., Soto-Mulet, L., L\u00f3pez-L\u00f3pez, M. & Hoogmartens, J. Reversed phase high performance liquid chromatographic determination of cefixime in bulk drugs. J. Liq. Chromatogr. Relat. Technol. 24, 2315\u20132324 (2001).","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"51859_CR20","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1365\/s10337-004-0432-4","volume":"60","author":"L Manna","year":"2004","unstructured":"Manna, L. & Valvo, L. Development and validation of a fast reversed-phase ion-pairing liquid chromatographic method for simultaneous determination of eight cephalosporin antibiotics in pharmaceutical formulations. Chromatographia 60, 645\u2013649 (2004).","journal-title":"Chromatographia"},{"key":"51859_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3797\/scipharm.1301-15","volume":"81","author":"Z Talebpour","year":"2013","unstructured":"Talebpour, Z. et al. Determination of cefixime by a validated stability-indicating HPLC method and identification of its related substances by LC-MS\/MS studies. Sci. Pharm. 81, 493\u2013503 (2013).","journal-title":"Sci. Pharm."},{"key":"51859_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jchromb.2005.02.015","volume":"819","author":"F Meng","year":"2005","unstructured":"Meng, F., Chen, X., Zeng, Y. & Zhong, D. Sensitive liquid chromatography\u2013tandem mass spectrometry method for the determination of cefixime in human plasma: Application to a pharmacokinetic study. J. Chromatogr. B. 819, 277\u2013282 (2005).","journal-title":"J. Chromatogr. B"},{"key":"51859_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2024.115724","volume":"697","author":"M Chaudhari","year":"2025","unstructured":"Chaudhari, M., Parmar, P. K. & Dudhat, K. Comparative validation of UV-spectrophotometry and RP-HPLC methods for cefixime and moxifloxacin analysis. Anal. Biochem. 697, 115724 (2025).","journal-title":"Anal. Biochem."},{"key":"51859_CR24","first-page":"8331762","volume":"2022","author":"U Nepal","year":"2022","unstructured":"Nepal, U., Panthi, V. K., Chaudhary, N. P. & Chaudhary, S. A validated RP-HPLC method for simultaneous determination of cefixime and clavulanic acid powder in pediatric oral suspension. Int. J. Anal. Chemi. 2022, 8331762 (2022).","journal-title":"Int. J. Anal. Chemi."},{"key":"51859_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2116\/analsci.19.281","volume":"19","author":"GA Saleh","year":"2003","unstructured":"Saleh, G. A., Askal, H. F., Darwish, I. A. & El-Shorbagi, A.-N. Spectroscopic analytical study for the charge-transfer complexation of certain cephalosporins with chloranilic acid. Anal. Sci. 19, 281\u2013288 (2003).","journal-title":"Anal. Sci."},{"key":"51859_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0731-7085(99)00281-2","volume":"22","author":"AFM El-Walily","year":"2000","unstructured":"El-Walily, A. F. M., Gazy, A. A., Belal, S. F. & Khamis, E. F. Quantitative determination of some thiazole cephalosporins through complexation with palladium (II) chloride. J. Pharm. Biomed. Anal. 22, 385\u2013392 (2000).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"51859_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13065-024-01168-5","volume":"18","author":"EA Madbouly","year":"2024","unstructured":"Madbouly, E. A., El-Shanawani, A. A., El-adl, S. M. & Abdelkhalek, A. S. Green chemometric-assisted UV-spectrophotometric methods for the determination of favipiravir, cefixime and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; Application in pharmaceutical form and spiked human plasma. BMC Chem. 18, 65\u201378 (2024).","journal-title":"BMC Chem."},{"key":"51859_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10812-015-0167-z","volume":"82","author":"MN Khan","year":"2015","unstructured":"Khan, M. N., Qayum, A., Rehman, U. U., Gulab, H. & Idrees, M. Spectrophotometric method for quantitative determination of cefixime in bulk and pharmaceutical preparation using Ferroin complex. J. Appl. Spectrosc. 82, 705\u2013711 (2015).","journal-title":"J. Appl. Spectrosc."},{"key":"51859_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0731-7085(03)00161-4","volume":"32","author":"LI Bebawy","year":"2003","unstructured":"Bebawy, L. I., Kelani, K. E. & Fattah, L. A. Fluorimetric determination of some antibiotics in raw material and dosage forms through ternary complex formation with terbium (Tb3+). J. Pharm. Biomed. Anal. 32, 1219\u20131225 (2003).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"51859_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10895-010-0745-7","volume":"21","author":"J Shah","year":"2011","unstructured":"Shah, J., Jan, M. R. & Shah, S. Inayatullah, Spectrofluorimetric method for determination and validation of cefixime in pharmaceutical preparations through derivatization with 2-cyanoacetamide. J. Fluoresc. 21, 579\u2013585 (2011).","journal-title":"J. Fluoresc."},{"key":"51859_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/bio.3971","volume":"36","author":"MN Khan","year":"2021","unstructured":"Khan, M. N., Irum, N. & Mursaleen, M. Determination of cefixime in pure form, in pharmaceutical products and biological samples through fluorescence quenching of eosin Y. Lumin. J. Biol. Chem. Lumin. 36, 515\u2013524 (2021).","journal-title":"Lumin. J. Biol. Chem. Lumin."},{"key":"51859_CR32","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0731-7085(98)00274-X","volume":"18","author":"S Eric-Jovanovic","year":"1998","unstructured":"Eric-Jovanovic, S., Agbaba, D., Zivanov-Stakic, D. & Vladimirov, S. HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms. J. Pharm. Biomed. Anal. 18, 893\u2013898 (1998).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"51859_CR33","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.talanta.2005.03.020","volume":"67","author":"A Golcu","year":"2005","unstructured":"Golcu, A., Dogan, B. & Ozkan, S. A. Anodic voltammetric behavior and determination of cefixime in pharmaceutical dosage forms and biological fluids. Talanta 67, 703\u2013712 (2005).","journal-title":"Talanta"},{"key":"51859_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ab.2010.07.027","volume":"407","author":"R Jain","year":"2010","unstructured":"Jain, R., Gupta, V. K., Jadon, N. & Radhapyari, K. Voltammetric determination of cefixime in pharmaceuticals and biological fluids. Anal. Biochem. 407, 79\u201388 (2010).","journal-title":"Anal. Biochem."},{"key":"51859_CR35","first-page":"81","volume":"19","author":"AR Solangi","year":"2007","unstructured":"Solangi, A. R., Memon, S. Q., Khuhawar, M. Y. & Bhanger, M. I. Quantitative analysis of eight cephalosporin antibiotics in pharmaceutical products and urine by capillary zone electrophoresis. Acta Chromatogr. 19, 81\u201396 (2007).","journal-title":"Acta Chromatogr."},{"key":"51859_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13065-025-01409-1","volume":"19","author":"B Fang","year":"2025","unstructured":"Fang, B., Jiang, D., Wang, S. & Chen, F. Simultaneous determination of five nitroimidazole antimicrobials in pharmaceuticals using HPLC-ESM and QAMS methods. BMC Chem. 19, 40\u201350 (2025).","journal-title":"BMC Chem."},{"key":"51859_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/sscp.202400270","volume":"8","author":"SK Koradia","year":"2025","unstructured":"Koradia, S. K., Dharsandia, G. A., Sen, A. K., Sen, D. B. & Patel, A. D. Concurrent analysis of racecadotril, ofloxacin, and ornidazole in a fixed-dose combination by RP\u2010HPLC\u2013DAD method. Sep. Sci. Plus 8, e202400270 (2025).","journal-title":"Sep. Sci. Plus"},{"key":"51859_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10826076.2024.2320625","volume":"47","author":"S Roychoudhury","year":"2024","unstructured":"Roychoudhury, S. et al. Development of a validated bioanalytical method for the simultaneous estimation of ornidazole and miconazole in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study. J. Liq. Chromatogr. Relat. Technol. 47, 35\u201343 (2024).","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"51859_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13065-023-00932-3","volume":"17","author":"KM Kelani","year":"2023","unstructured":"Kelani, K. M., Gad, A. G., Fayez, Y. M., Mahmoud, A. M. & Abdel-Raoof, A. M. Three developed spectrophotometric methods for determination of a mixture of ofloxacin and ornidazole; application of greenness assessment tools. BMC Chem. 17, 16\u201331 (2023).","journal-title":"BMC Chem."},{"key":"51859_CR40","first-page":"318","volume":"1","author":"G Mubeen","year":"2009","unstructured":"Mubeen, G., Prakash, V., Somashekar, P. & Uvesh, K. Spectrophotometric method for determination of ornidazole. Int. J. Chem. Tech Res. 1, 318\u2013321 (2009).","journal-title":"Int. J. Chem. Tech Res."},{"key":"51859_CR41","first-page":"207","volume":"25","author":"KM Darwish","year":"2012","unstructured":"Darwish, K. M., Salama, I., Mostafa, S. & El-Sadek, M. Extractional spectrophotometric analysis of metronidazole, tinidazole, ornidazole and secnidazole bases through acid-dye complexation using bromothymol blue dye. Pak. J. Pharm. Sci. 25, 207\u2013217 (2012).","journal-title":"Pak. J. Pharm. Sci."},{"key":"51859_CR42","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/chromsci\/45.8.531","volume":"45","author":"S Chepurwar","year":"2007","unstructured":"Chepurwar, S., Shirkhedkar, A., Bari, S., Fursule, R. & Surana, S. Validated HPTLC method for simultaneous estimation of levofloxacin hemihydrate and ornidazole in pharmaceutical dosage form. J. Chromatogr. Sci. 45, 531\u2013536 (2007).","journal-title":"J. Chromatogr. Sci."},{"key":"51859_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/chromsci\/48.1.26","volume":"48","author":"PN Ranjane","year":"2010","unstructured":"Ranjane, P. N., Gandhi, S. V., Kadukar, S. S. & Bothara, K. G. HPTLC determination of cefuroxime axetil and ornidazole in combined tablet dosage form. J. Chromatogr. Sci. 48, 26\u201328 (2010).","journal-title":"J. Chromatogr. Sci."},{"key":"51859_CR44","first-page":"115","volume":"2","author":"A Rote","year":"2011","unstructured":"Rote, A. & Kumbhoje, P. Development and validation of HPTLC method for simultaneous estimation of gatifloxacin and ornidazole in human plasma. J. Chromatogr. Sep. Tech. 2, 115\u2013117 (2011).","journal-title":"J. Chromatogr. Sep. Tech."},{"key":"51859_CR45","doi-asserted-by":"publisher","first-page":"19196","DOI":"10.1039\/D1RA01346G","volume":"11","author":"AG Gad","year":"2021","unstructured":"Gad, A. G., Fayez, Y. M., Kelani, K. M. & Mahmoud, A. M. TLC-smartphone in antibiotics determination and low-quality pharmaceuticals detection. RSC Adv. 11, 19196\u201319202 (2021).","journal-title":"RSC Adv."},{"key":"51859_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0378-5173(97)00208-1","volume":"157","author":"SA \u00d6zkan","year":"1997","unstructured":"\u00d6zkan, S. A., \u015eenturk, Z. & Biryol, I. Determination of ornidazole in pharmaceutical dosage forms based on reduction at an activated glassy carbon electrode 1 Presented at the 5th International Symposium on Drug Analysis, Leuven (Belgium), Sept 12\u201315, 1995.1. Int. J. Pharm. 157, 137\u2013144 (1997).","journal-title":"Int. J. Pharm."},{"key":"51859_CR47","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2174\/157341209789649140","volume":"5","author":"S Turan","year":"2009","unstructured":"Turan, S., Durmus, Z. & Kili\u00e7, E. Electrochemical behavior of ornidazole and its adsorptive stripping determination in pharmaceuticals. Curr. Pharm. Anal. 5, 416\u2013423 (2009).","journal-title":"Curr. Pharm. Anal."},{"key":"51859_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2022.100850","volume":"39","author":"FE Ettadili","year":"2022","unstructured":"Ettadili, F. E. et al. Electrochemical determination of ornidazole at silver electrode: Analytical application in human blood. Chem. Data Collect. 39, 100850 (2022).","journal-title":"Chem. Data Collect."},{"key":"51859_CR49","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/bmc.1251","volume":"23","author":"KL See","year":"2009","unstructured":"See, K. L., Elbashir, A. A., Saad, B., Ali, A. S. M. & Aboul-Enein, H. Y. Simultaneous determination of ofloxacin and ornidazole in pharmaceutical preparations by capillary zone electrophoresis. Biomed. Chromatogr. 23, 1283\u20131290 (2009).","journal-title":"Biomed. Chromatogr."},{"key":"51859_CR50","first-page":"1124","volume":"4","author":"GJ Kher","year":"2012","unstructured":"Kher, G. J., Ram, V. R., Pandiya, G. G. & Joshi, H. S. Validated LC method for simultaneous analysis of cefixime and ornidazole in commercial tablets. Int. J. ChemTech Res. 4, 1124\u20131136 (2012).","journal-title":"Int. J. ChemTech Res."},{"key":"51859_CR51","first-page":"747","volume":"3","author":"R Ramesh","year":"2012","unstructured":"Ramesh, R., Malothu, R., Vasanth, P. & Srinivasa Rao, Y. Development and validation of an rapid RP-HPLC method for simultaneous determination of drug cefixime and ornidazole in tablet dosage form. Int. J. Biol. Pharm. Res. 3, 747\u2013751 (2012).","journal-title":"Int. J. Biol. Pharm. Res."},{"key":"51859_CR52","first-page":"4297","volume":"19","author":"N Sreekanth","year":"2007","unstructured":"Sreekanth, N. et al. Validated simultaneous estimation of ornidazole and cefixime by RP-HPLC in pure and pharmaceutical dosage form. Asian J. Chem. 19, 4297\u20134302 (2007).","journal-title":"Asian J. Chem."},{"key":"51859_CR53","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.31788\/RJC.2018.1144093","volume":"11","author":"SK Palacharla","year":"2018","unstructured":"Palacharla, S. K. & Mohan, G. K. Stability indicating HPLC method for the quantification of cefixime, ornidazole and moxifloxacin in solid dosage forms. Rasayan J. Chem. 11, 1696\u20131714 (2018).","journal-title":"Rasayan J. Chem."},{"key":"51859_CR54","doi-asserted-by":"publisher","DOI":"10.13005\/bbra\/1064","author":"JR Babu","year":"2012","unstructured":"Babu, J. R., Vidyadhara, S. & Anusha, V. Analytical method development and validation for simultaneous estimation of Cefixime Trihydrate and Ornidazole in tablet dosage form by RP-HPLC. Biosci. Biotechnol. Res. Asia https:\/\/doi.org\/10.13005\/bbra\/1064 (2012).","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"51859_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5958\/2231-5675.2016.00036.3","volume":"6","author":"S Selvakumar","year":"2016","unstructured":"Selvakumar, S., Ravichandran, S. & Matsyagiri, L. Development and validation of analytical method for simultaneous estimation of ornidazole and cefixime trihydrate tablet dosage forms by UV spectroscopy. Asian J. Pharm. Anal. 6, 246\u2013252 (2016).","journal-title":"Asian J. Pharm. Anal."},{"key":"51859_CR56","first-page":"3621","volume":"19","author":"N Sreekanth","year":"2007","unstructured":"Sreekanth, N. et al. Simultaneous estimation and validation of ornidazole and cefixime by HPTLC in pure and pharmaceutical dosage forms. Asian J. Chem. 19, 3621\u20133626 (2007).","journal-title":"Asian J. Chem."},{"key":"51859_CR57","unstructured":"https:\/\/drugcarts.com\/product\/cefluv-oz-200mg-500mg-tablet. Accessed 11 May 2025."},{"key":"51859_CR58","unstructured":"https:\/\/www.medicines.org.uk\/emc\/product\/15047\/smpc. Accessed 11 May 2025."},{"key":"51859_CR59","unstructured":"https:\/\/www.medsafe.govt.nz\/consumers\/cmi\/a\/arrowornidazole.pdf. Accessed 11 May 2025."},{"key":"51859_CR60","first-page":"77","volume":"34","author":"FA Ibrahim","year":"2019","unstructured":"Ibrahim, F. A., Fathy, M. E. & Elmansi, H. M. Highly sensitive spectrofluorimetric method for rapid determination of orciprenaline in biological fluids and pharmaceuticals. Lumin.: J. Biol. Chem. Lumin. 34, 77\u201383 (2019).","journal-title":"Lumin.: J. Biol. Chem. Lumin."},{"key":"51859_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2011.04.023","volume":"56","author":"B Dejaegher","year":"2011","unstructured":"Dejaegher, B. & Heyden, Y. V. Experimental designs and their recent advances in set-up, data interpretation, and analytical applications. J. Pharm. Biomed. Anal. 56, 141\u2013158 (2011).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"51859_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26774-y","volume":"12","author":"WN Abd-AlGhafar","year":"2022","unstructured":"Abd-AlGhafar, W. N., Aly, F. A., Sheribah, Z. A. & Saad, S. Factorial design-assisted reverse phase HPLC\u2013UV approach for the concurrent estimation of cetirizine and azelastine in aqueous humor. Sci. Rep. 12, 22435 (2022).","journal-title":"Sci. Rep."},{"key":"51859_CR63","unstructured":"ICH Harmonised Tripartite, Validation of Analytical Procedures: Text and Methodology Q2(R1). In International Conference on Harmonization, Geneva, Switzerland, 11\u201312 (2005)."},{"key":"51859_CR64","volume-title":"Statistics and Chemometrics for Aanalytical Chemistry","author":"JC Miller","year":"2005","unstructured":"Miller, J. C. & Miller, J. N. Statistics and Chemometrics for Aanalytical Chemistry\u00a0, 5th edn. (Harlow, 2005).","edition":"5"},{"key":"51859_CR65","unstructured":"The United States Pharmacopoeia, 44th edition and National Formulary 39th edition (Rockville, U.S. Pharmacopoeia Convention, 2021)."},{"key":"51859_CR66","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1039\/c0gc00667j","volume":"13","author":"Y Gaber","year":"2011","unstructured":"Gaber, Y., T\u00f6rnvall, U., Kumar, M., Amin, M. A. & Hatti-Kaul, R. HPLC-EAT (Environmental Assessment Tool): A tool for profiling safety, health and environmental impacts of liquid chromatography methods. Green Chem. 13, 2021\u20132025 (2011).","journal-title":"Green Chem."},{"key":"51859_CR67","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1039\/C5AY01202C","volume":"7","author":"D Gallart-Mateu","year":"2015","unstructured":"Gallart-Mateu, D., Cervera, M., Armenta, S. & De La Guardia, M. The importance of incorporating a waste detoxification step in analytical methodologies. Anal. Methods 7, 5702\u20135706 (2015).","journal-title":"Anal. Methods"},{"key":"51859_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.greeac.2024.100126","volume":"10","author":"FR Mansour","year":"2024","unstructured":"Mansour, F. R., Omer, K. M. & P\u0142otka-Wasylka, J. A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness. Green Anal. Chem. 10, 100126 (2024).","journal-title":"Green Anal. Chem."},{"key":"51859_CR69","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical greenness metric approach and software. Anal. Chem. 92, 10076\u201310082 (2020).","journal-title":"Anal. Chem."},{"key":"51859_CR70","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: A new tool for the evaluation of method practicality. Green Chem. 25, 7598\u20137604 (2023).","journal-title":"Green Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51859-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:02:38Z","timestamp":1779811358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51859-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51859-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16309"}}